These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 28118775)
1. Renoprotective effects of a dipeptidyl peptidase 4 inhibitor in a mouse model of progressive renal fibrosis. Uchida T; Oda T; Matsubara H; Watanabe A; Takechi H; Oshima N; Sakurai Y; Kumagai H Ren Fail; 2017 Nov; 39(1):340-349. PubMed ID: 28118775 [TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory role of DPP-4 inhibitors in a nondiabetic model of glomerular injury. Higashijima Y; Tanaka T; Yamaguchi J; Tanaka S; Nangaku M Am J Physiol Renal Physiol; 2015 Apr; 308(8):F878-87. PubMed ID: 25656369 [TBL] [Abstract][Full Text] [Related]
3. Brilliant blue G, a P2X7 receptor antagonist, attenuates early phase of renal inflammation, interstitial fibrosis and is associated with renal cell proliferation in ureteral obstruction in rats. Pereira JMS; Barreira AL; Gomes CR; Ornellas FM; Ornellas DS; Miranda LC; Cardoso LR; Coutinho-Silva R; Schanaider A; Morales MM; Leite M; Takiya CM BMC Nephrol; 2020 May; 21(1):206. PubMed ID: 32471386 [TBL] [Abstract][Full Text] [Related]
4. Dipeptidyl peptidase- IV inhibitor alogliptin improves stress-induced insulin resistance and prothrombotic state in a murine model. Yisireyili M; Takeshita K; Hayashi M; Wu H; Uchida Y; Yamamoto K; Kikuchi R; Hao CN; Nakayama T; Cheng XW; Matsushita T; Nakamura S; Murohara T Psychoneuroendocrinology; 2016 Nov; 73():186-195. PubMed ID: 27509090 [TBL] [Abstract][Full Text] [Related]
5. Gemigliptin Attenuates Renal Fibrosis Through Down-Regulation of the NLRP3 Inflammasome. Seo JB; Choi YK; Woo HI; Jung YA; Lee S; Lee S; Park M; Lee IK; Jung GS; Park KG Diabetes Metab J; 2019 Dec; 43(6):830-839. PubMed ID: 30877711 [TBL] [Abstract][Full Text] [Related]
6. Glucose-independent renoprotective mechanisms of the tissue dipeptidyl peptidase-4 inhibitor, saxagliptin, in Dahl salt-sensitive hypertensive rats. Uchii M; Kimoto N; Sakai M; Kitayama T; Kunori S Eur J Pharmacol; 2016 Jul; 783():56-63. PubMed ID: 27063445 [TBL] [Abstract][Full Text] [Related]
7. Evogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Attenuates Renal Fibrosis Caused by Unilateral Ureteral Obstruction in Mice. Kim MJ; Kim NY; Jung YA; Lee S; Jung GS; Kim JG; Lee IK; Lee S; Choi YK; Park KG Diabetes Metab J; 2020 Feb; 44(1):186-192. PubMed ID: 31701692 [TBL] [Abstract][Full Text] [Related]
8. Ulinastatin attenuates renal interstitial inflammation and inhibits fibrosis progression in rats under unilateral ureteral obstruction. Jiang GT; Chen X; Li D; An HX; Jiao JD Mol Med Rep; 2014 Sep; 10(3):1501-8. PubMed ID: 24926571 [TBL] [Abstract][Full Text] [Related]
9. Aliskiren ameliorates renal inflammation and fibrosis induced by unilateral ureteral obstruction in mice. Choi DE; Jeong JY; Lim BJ; Chang YK; Na KR; Shin YT; Lee KW J Urol; 2011 Aug; 186(2):694-701. PubMed ID: 21683401 [TBL] [Abstract][Full Text] [Related]
10. Alogliptin alleviates liver fibrosis via suppression of activated hepatic stellate cell. Zhang H; Sun D; Wang G; Cui S; Field RA; Li J; Zang Y Biochem Biophys Res Commun; 2019 Apr; 511(2):387-393. PubMed ID: 30797555 [TBL] [Abstract][Full Text] [Related]
11. Additive antifibrotic effects of pioglitazone and candesartan on experimental renal fibrosis in mice. Higashi K; Oda T; Kushiyama T; Hyodo T; Yamada M; Suzuki S; Sakurai Y; Miura S; Kumagai H Nephrology (Carlton); 2010 Apr; 15(3):327-35. PubMed ID: 20470302 [TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease. Choi HS; Song JH; Kim IJ; Joo SY; Eom GH; Kim I; Cha H; Cho JM; Ma SK; Kim SW; Bae EH Sci Rep; 2018 Aug; 8(1):11546. PubMed ID: 30068917 [TBL] [Abstract][Full Text] [Related]
13. Renal Fibrosis, Immune Cell Infiltration and Changes of TRPC Channel Expression after Unilateral Ureteral Obstruction in Trpc6-/- Mice. Kong W; Haschler TN; Nürnberg B; Krämer S; Gollasch M; Markó L Cell Physiol Biochem; 2019; 52(6):1484-1502. PubMed ID: 31099508 [TBL] [Abstract][Full Text] [Related]
14. Dipeptidyl peptidase IV inhibitor protects against renal interstitial fibrosis in a mouse model of ureteral obstruction. Min HS; Kim JE; Lee MH; Song HK; Kang YS; Lee MJ; Lee JE; Kim HW; Cha JJ; Chung YY; Hyun YY; Han JY; Cha DR Lab Invest; 2014 Jun; 94(6):598-607. PubMed ID: 24687121 [TBL] [Abstract][Full Text] [Related]
15. The antifibrotic and anti-inflammatory effects of icariin on the kidney in a unilateral ureteral obstruction mouse model. Chen HA; Chen CM; Guan SS; Chiang CK; Wu CT; Liu SH Phytomedicine; 2019 Jun; 59():152917. PubMed ID: 30978648 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of GLP-1 receptor-independent renoprotective effects of the dipeptidyl peptidase type 4 inhibitor linagliptin in GLP-1 receptor knockout mice with 5/6 nephrectomy. Hasan AA; von Websky K; Reichetzeder C; Tsuprykov O; Gaballa MMS; Guo J; Zeng S; Delić D; Tammen H; Klein T; Kleuser B; Hocher B Kidney Int; 2019 Jun; 95(6):1373-1388. PubMed ID: 30979564 [TBL] [Abstract][Full Text] [Related]
17. Sorafenib Inhibits Renal Fibrosis Induced by Unilateral Ureteral Obstruction via Inhibition of Macrophage Infiltration. Ma W; Tao L; Wang X; Liu Q; Zhang W; Li Q; He C; Xue D; Zhang J; Liu C Cell Physiol Biochem; 2016; 39(5):1837-1849. PubMed ID: 27744426 [TBL] [Abstract][Full Text] [Related]
18. Orally administered dipeptidyl peptidase-4 inhibitor (alogliptin) prevents abdominal aortic aneurysm formation through an antioxidant effect in rats. Bao W; Morimoto K; Hasegawa T; Sasaki N; Yamashita T; Hirata K; Okita Y; Okada K J Vasc Surg; 2014 Apr; 59(4):1098-108. PubMed ID: 23790558 [TBL] [Abstract][Full Text] [Related]
19. H Zhou Y; Zhu X; Wang X; Peng Y; Du J; Yin H; Yang H; Ni X; Zhang W Exp Cell Res; 2020 Feb; 387(1):111779. PubMed ID: 31846625 [TBL] [Abstract][Full Text] [Related]
20. Ulinastatin inhibits unilateral ureteral obstruction-induced renal interstitial fibrosis in rats via transforming growth factor β (TGF-β)/Smad signalling pathways. Ning XH; Ge XF; Cui Y; An HX Int Immunopharmacol; 2013 Feb; 15(2):406-13. PubMed ID: 23318600 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]